First chat of 2019 - showcasing again the honest brokers of nephrology trials with another negative trial. Also note we will be having a NephJC Asia chat starting this week!
This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.
This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.